Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Anti-angiogenesis and anti-immunosuppression gene therapy through targeting COUP-TFII in an in situ glioblastoma mouse model

Item Type:Article
Title:Anti-angiogenesis and anti-immunosuppression gene therapy through targeting COUP-TFII in an in situ glioblastoma mouse model
Creators Name:Wang, F., Zhang, S., Sun, F., Chen, W., Liu, C., Dong, H., Cui, B., Li, L., Sun, C., Du, W., Liu, B., Fan, W., Deng, J., Schmitt, C.A., Wang, X. and Du, J.
Abstract:Glioblastoma (GBM) is the most common and aggressive primary brain cancer; angiogenesis and immunosuppression exacerbate GBM progression. COUP-TFII demonstrates pro-angiogenesis activity; however, its role in glioma progression remains unclear. This study revealed that COUP-TFII promotes angiogenesis in gliomas by inducing transdifferentiation of glioma cells into endothelial-like cells. Mechanistic investigation suggested that COUP-TFII as a transcription factor exerts its function via binding to the promoter of TXNIP. Interestingly, COUP-TFII knockdown attenuated tumorigenesis and tumor progression in an immunocompetent mouse model but promoted tumor progression in an immuno-deficient mouse model. As an explanation, repression of COUP-TFII induces cellular senescence and activates immune surveillance in glioma cells in vitro and in vivo. In addition, we used heparin–polyethyleneimine (HPEI) nanoparticles to deliver COUP-TFII shRNA, which regulated tumor angiogenesis and immunosuppression in an in situ GBM mouse model. This study provides a novel strategy and potential therapeutic targets to treat GBM.
Keywords:Animal Disease Models, Brain Neoplasms, COUP Transcription Factor II, Genetic Therapy, Glioblastoma, Immunosuppression Therapy, Nanoparticles, Pathologic Neovascularization, Tumor Cell Line, Animals, Mice
Source:Cancer Gene Therapy
ISSN:0929-1903
Publisher:Nature Publishing Group
Volume:31
Number:8
Page Range:1135-1150
Date:August 2024
Official Publication:https://doi.org/10.1038/s41417-024-00799-z
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library